This "Training Program in the Neurobiology of Drug Abuse" at Emory University is a program for both predoctoral and postdoctoral fellows in drug abuse research. The goals are: to assist trainees to identify "cutting edge" problems, to obtain didactic training in drug abuse if needed, and to help trainees become independent researchers in drug abuse. Other aspects of career development are available as well. This is the only formal program in drug abuse at Emory - ever, and it has succeeded in bringing a focus to this field, in presenting far more seminars and symposia than were ever available in drug abuse, and in offering a coherent and guided training program in drug abuse for the first time. The Program Director (PD) is Dr. Michael Kuhar, Candler Professor of Neuropharmacology and Chief of the Neuroscience Division at the Yerkes Primate Center.of Emory. He is an experienced and accomplished scientist, administrator, and mentor. There are 18 additional training faculty that offer expertise in a number of relevant areas including brain imaging, genetics, molecular pharmacology, neurotransmitter systems, medications development, and behavioral models in drug abuse. The training programs are embedded in the rigorous and strong programs that already exist at Emory. The NIDA training program builds on this outstanding infrastructure and adds specific opportunities in drug abuse mentoring. The few trainees that have graduated or finished their post doc training have moved on to appropriate positions. A large number of the trainees are excellent, highly competitive and successful in obtaining independent training grants as well. Mechanisms are in place to evaluate the program, the faculty and to elicit useful suggestions for the program. This program has been outstanding in recruiting underrepresented minorities (URMs);almost 30% of our trainees are URMs. Emory and this training program also offer strong and continuing training in the responsible conduct of research. Overall, this is a strong program that adds new training in drug abuse research in a visible and effective way.

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Special Emphasis Panel (ZDA1-EXL-T (04))
Program Officer
Babecki, Beth
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Emory University
Schools of Medicine
United States
Zip Code
Ogbonmwan, Yvonne E; Sciolino, Natale R; Groves-Chapman, Jessica L et al. (2015) The galanin receptor agonist, galnon, attenuates cocaine-induced reinstatement and dopamine overflow in the frontal cortex. Addict Biol 20:701-13
Ogbonmwan, Yvonne E; Schroeder, Jason P; Holmes, Philip V et al. (2015) The effects of post-extinction exercise on cocaine-primed and stress-induced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl) 232:1395-403
Galvan, Adriana; Hu, Xing; Rommelfanger, Karen S et al. (2014) Localization and function of dopamine receptors in the subthalamic nucleus of normal and parkinsonian monkeys. J Neurophysiol 112:467-79
Rojas, Asheebo; Gueorguieva, Paoula; Lelutiu, Nadia et al. (2014) The prostaglandin EP1 receptor potentiates kainate receptor activation via a protein kinase C pathway and exacerbates status epilepticus. Neurobiol Dis 70:74-89
Cooper, Debra A; Kimmel, Heather L; Manvich, Daniel F et al. (2014) Effects of pharmacologic dopamine ?-hydroxylase inhibition on cocaine-induced reinstatement and dopamine neurochemistry in squirrel monkeys. J Pharmacol Exp Ther 350:144-52
Gaval-Cruz, Meriem; Goertz, Richard B; Puttick, Daniel J et al. (2014) Chronic loss of noradrenergic tone produces ?-arrestin2-mediated cocaine hypersensitivity and alters cellular D2 responses in the nucleus accumbens. Addict Biol :
Job, Martin O; Perry, Joanna; Shen, Li L et al. (2014) Cocaine-and-Amphetamine Regulated Transcript (CART) peptide attenuates dopamine- and cocaine-mediated locomotor activity in both male and female rats: lack of sex differences. Neuropeptides 48:75-81
Lohr, Kelly M; Bernstein, Alison I; Stout, Kristen A et al. (2014) Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo. Proc Natl Acad Sci U S A 111:9977-82
Hinton, Elizabeth A; Wheeler, Marina G; Gourley, Shannon L (2014) Early-life cocaine interferes with BDNF-mediated behavioral plasticity. Learn Mem 21:253-7
Haeseleer, Fran├žoise; Sokal, Izabela; Gregory, Frederick D et al. (2013) Protein phosphatase 2A dephosphorylates CaBP4 and regulates CaBP4 function. Invest Ophthalmol Vis Sci 54:1214-26

Showing the most recent 10 out of 52 publications